Brief Report: Renal replacement therapy in Korea, 2010

被引:29
作者
Jin, Dong Chan [1 ,2 ]
Ha, Il Soo [1 ,3 ]
Kim, Nam Ho [1 ,4 ]
Lee, Seoung Woo [1 ,5 ]
Lee, Jong Soo [1 ,6 ]
Yoon, Sung Ro [1 ,7 ]
Kim, Byung Su [1 ,2 ]
机构
[1] Korean Soc Nephrol, ESRD Registry Comm, Seoul, South Korea
[2] Catholic Univ Korea, Coll Med, Dept Internal Med, Seoul, South Korea
[3] Seoul Natl Univ, Coll Med, Dept Pediat, Seoul, South Korea
[4] Chonnam Natl Univ, Coll Med, Dept Internal Med, Gwangju, South Korea
[5] Inha Univ, Coll Med, Dept Internal Med, Inchon, South Korea
[6] Univ Ulsan, Coll Med, Dept Internal Med, Ulsan, South Korea
[7] Kunyang Univ, Coll Med, Dept Internal Med, Daejeon, South Korea
关键词
End stage renal disease; Hemodialysis; Korea; Peritoneal dialysis;
D O I
10.1016/j.krcp.2012.01.005
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
The Korean Society of Nephrology (KSN) launched the official End-Stage Renal Disease (ESRD) Patient Registry in 1985 and the Internet online registry program was opened in 2001. The ESRD Registry Committee of KSN has collected data on dialysis therapy in Korea through the online registry program in the KSN Internet website. The increasing number of elderly people and diabetic patients in Korea has resulted in a very rapid increase in the number of ESRD patients. The total number of ESRD patients was 58,860 (hemodialysis [HD], 39,509; peritoneal dialysis [PD], 7309; and functioning kidney transplant [KT], 12,042). The prevalence of ESRD was 1144.4 patients per million population (PMP), and the proportion of renal replacement therapy was HD, 67.1%; PD, 12.4%; and KT, 20.5%. The number of new ESRD patients in 2010 was 9335 (HD, 7204; PD, 867; and KT, 1264; the incidence rate was 181.5 PMP). The primary causes of ESRD were diabetic nephropathy (45.2%), hypertensive nephrosclerosis (19.2%), and chronic glomerulonephritis (11.3%). The mean urea reduction ratio was 67.9% in male HD patients and 73.9% in female HD patients. The mean Kt/V was 1.394 in male patients and 1.659 in female patients. Five-year survival rates of male and female dialysis patients were 64.9% and 67.3%, respectively. (C) 2012. The Korean Society of Nephrology. Published by Elsevier. This is an open access article under the CC BY-NC-ND license
引用
收藏
页码:62 / 71
页数:10
相关论文
共 2 条
[1]
ESRD Registry Committee, 2010, KOR SOC NEPHR CURR R
[2]
USRDS, ANN REP US REN DAT S